$GTCH SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) concluded its large-scale testing for its qTerm GEN III prototype device. Based on the collected data GBT will attempt to finalize the device’s accuracy and features. The company developed a web-based widget to demonstrate telemedicine capabilities. The widget enables viewing a user’s vitals anywhere in the world through a web-based interface. The widget includes analytics, historical data recordation and categorization of abnormal results.

https://www.wsj.com/articles/gbt-has-conclude...33?tesla=y